157 related articles for article (PubMed ID: 37113556)
21. Establishment and validation of a prognostic model based on HRR-related lncRNAs in colon adenocarcinoma.
Tang X; Lin Y; He J; Luo X; Liang J; Zhu X; Li T
World J Surg Oncol; 2022 Mar; 20(1):74. PubMed ID: 35264195
[TBL] [Abstract][Full Text] [Related]
22.
Liu L; Jia S; Jin X; Zhu S; Zhang S
DNA Cell Biol; 2021 Sep; 40(9):1158-1166. PubMed ID: 34415792
[TBL] [Abstract][Full Text] [Related]
23. Spatially aware graph neural networks and cross-level molecular profile prediction in colon cancer histopathology: a retrospective multi-cohort study.
Ding K; Zhou M; Wang H; Zhang S; Metaxas DN
Lancet Digit Health; 2022 Nov; 4(11):e787-e795. PubMed ID: 36307192
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive analysis of the prognosis, tumor microenvironment, and immunotherapy response of SDHs in colon adenocarcinoma.
Nan H; Guo P; Fan J; Zeng W; Hu C; Zheng C; Pan B; Cao Y; Ge Y; Xue X; Li W; Lin K
Front Immunol; 2023; 14():1093974. PubMed ID: 36949947
[TBL] [Abstract][Full Text] [Related]
25. Notum palmitoleoyl-protein carboxylesterase regulates Fas cell surface death receptor-mediated apoptosis via the Wnt signaling pathway in colon adenocarcinoma.
Gong H; Niu Q; Zhou Y; Wang YX; Xu XF; Hou KZ
Bioengineered; 2021 Dec; 12(1):5241-5252. PubMed ID: 34402722
[TBL] [Abstract][Full Text] [Related]
26. Mining novel cell glycolysis related gene markers that can predict the survival of colon adenocarcinoma patients.
Chen S; Cao G; Wu W; Lu Y; He X; Yang L; Chen K; Chen B; Xiong M
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32744303
[TBL] [Abstract][Full Text] [Related]
27. Long non-coding RNA ZEB1-AS1 promotes colon adenocarcinoma malignant progression via miR-455-3p/PAK2 axis.
Ni X; Ding Y; Yuan H; Shao J; Yan Y; Guo R; Luan W; Xu M
Cell Prolif; 2020 Jan; 53(1):e12723. PubMed ID: 31828845
[TBL] [Abstract][Full Text] [Related]
28. Methyltransferase like 3 enhances pinin mRNA stability through N
He M; Jiang D; Xun A; Yang J; Luo Q; Wu H
Exp Physiol; 2022 Nov; 107(11):1283-1297. PubMed ID: 35996844
[TBL] [Abstract][Full Text] [Related]
29. Identification of gene modules and hub genes in colon adenocarcinoma associated with pathological stage based on WGCNA analysis.
Wang H; Liu J; Li J; Zang D; Wang X; Chen Y; Gu T; Su W; Song N
Cancer Genet; 2020 Apr; 242():1-7. PubMed ID: 32036224
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive analysis of the differential expression and prognostic value of COL1A2 in colon adenocarcinoma.
Jin JJ; Zheng T; Xu XX; Zheng L; Li FY; Li XX; Zhou L
Aging (Albany NY); 2022 Sep; 14(18):7390-7407. PubMed ID: 36057263
[TBL] [Abstract][Full Text] [Related]
31. Cysteine- and glycine-rich protein 1 predicts prognosis and therapy response in patients with acute myeloid leukemia.
Hao Q; Liu Y; Liu Y; Shi L; Chen Y; Yang L; Jiang Z; Liu Y; Wang C; Wang S; Sun L
Clin Exp Med; 2024 Mar; 24(1):57. PubMed ID: 38546813
[TBL] [Abstract][Full Text] [Related]
32. Identification of a novel glycolysis-related gene signature for predicting the survival of patients with colon adenocarcinoma.
Yi K; Wu J; Tang X; Zhang Q; Wang B; Wang F
Scand J Gastroenterol; 2022 Feb; 57(2):214-221. PubMed ID: 34644216
[TBL] [Abstract][Full Text] [Related]
33. High expression of PI4K2A predicted poor prognosis of colon adenocarcinoma (COAD) and correlated with immunity.
Huang X; Cao Y; Bao P; Zhu B; Cheng Z
Cancer Med; 2023 Jan; 12(1):837-851. PubMed ID: 35634680
[TBL] [Abstract][Full Text] [Related]
34. High expression of homeobox B2 predicts poor survival of colon adenocarcinoma by enhancing tumor proliferation and invasion.
Li S; Wang Y; Xuan Z; Zhang Y; Miao Z
Ir J Med Sci; 2023 Feb; 192(1):89-97. PubMed ID: 35320486
[TBL] [Abstract][Full Text] [Related]
35. ETV4 transcriptionally activates HES1 and promotes Stat3 phosphorylation to promote malignant behaviors of colon adenocarcinoma.
Yao D; Bao Z; Qian X; Yang Y; Mao Z
Cell Biol Int; 2021 Oct; 45(10):2129-2139. PubMed ID: 34270850
[TBL] [Abstract][Full Text] [Related]
36. Fraxetin inhibits the growth of colon adenocarcinoma cells via the Janus kinase 2/signal transducer and activator of transcription 3 signalling pathway.
Ren S; Xing Y; Wang C; Jiang F; Liu G; Li Z; Jiang T; Zhu Y; Piao D
Int J Biochem Cell Biol; 2020 Aug; 125():105777. PubMed ID: 32504672
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive Analysis of the Expression, Prognostic Value, and Immune Infiltration Activities of GABRD in Colon Adenocarcinoma.
Huang F; Wang Z; Zhu L; Lin C; Wang JX
Mediators Inflamm; 2023; 2023():8709458. PubMed ID: 37181811
[TBL] [Abstract][Full Text] [Related]
38. SSR4 as a prognostic biomarker and related with immune infiltration cells in colon adenocarcinoma.
He W; Wang B; He J; Zhao Y; Zhao W
Expert Rev Mol Diagn; 2022 Feb; 22(2):223-231. PubMed ID: 34904499
[TBL] [Abstract][Full Text] [Related]
39. In silico development and clinical validation of novel 8 gene signature based on lipid metabolism related genes in colon adenocarcinoma.
Jiang C; Liu Y; Wen S; Xu C; Gu L
Pharmacol Res; 2021 Jul; 169():105644. PubMed ID: 33940186
[TBL] [Abstract][Full Text] [Related]
40. High miR-31-5p expression promotes colon adenocarcinoma progression by targeting TNS1.
Mi B; Li Q; Li T; Liu G; Sai J
Aging (Albany NY); 2020 Apr; 12(8):7480-7490. PubMed ID: 32315285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
